Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eni SpA (E) vs Invesco Ltd. (IVZ) Price & Performance

Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

Eni SpA vs Invesco Ltd. — how do they compare? Eni SpA trades at $55.41 (market cap $78.10B), while Invesco Ltd. trades at $30.09 (market cap $13.47B). The key difference: Eni SpA is far larger — about 5.8× Invesco Ltd.'s market cap, and Eni SpA pays the higher dividend (4.52%). Which is the better fit depends on your goals — on Pluang, investors hold Eni SpA for 53 Days and Invesco Ltd. for 77 Days on average.

EIVZ
Market Cap
$78.10B$13.47B
Volume
296,5164,447,526
Sector
EnergyFinancials
52-Week High
$57.61$33.31
52-Week Low
$34.03$22.44
Typical Hold Time
53 Days77 Days
Enterprise Value
$102.75B$23.63B
Dividend Yield
4.52%2.82%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eni SpA

Eni (E) trades at $55.62, up 1.96% today, amid a bearish technical signal. Revenue has declined from $132.5B in 2022 to $82.15B in 2025, though net income margin improved to 5.97% in 2026. The company maintains solid cash flow and a low P/E of 12.53. Recent news highlights expansion in humanoid robotics, LNG projects in Argentina, and fuel discounts in Italy, indicating strategic diversification and customer support initiatives.

The outlook is mixed; valuation appears attractive with low multiples, and analyst consensus leans hold (61.53%). However, declining revenue, recent earnings misses, and bearish technicals pose near-term risks. Upside depends on execution of new projects and stabilization of energy markets, while volatility in oil prices remains a key sensitivity.

Invesco Ltd.

Invesco (IVZ) trades at $30.50, showing modest daily gains of 0.39%. The stock presents mixed signals with bearish technical indicators but positive analyst sentiment featuring 12 buy ratings and a $33.71 consensus target. Recent financials show revenue growth to $6.38B in 2025, though net income remains negative at -$281.70M. The company maintains strong operating cash flow of $1.53B and recently announced a $0.22 dividend for H2-2026.

Investment outlook balances analyst optimism against fundamental challenges. The 8.8% upside to consensus target suggests potential, but negative profitability metrics and bearish technicals warrant caution. Key catalysts include Q3 2026 earnings release on October 27 and continued AUM growth momentum, while risks center on margin pressure and market volatility affecting asset management revenues.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

E
63% Buy37% Sell
Avg holding period · 53 Days
IVZ

No sentiment data available yet.

Top news

Latest headlines on both assets

About Eni SpA

Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude

Read more on E →

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ →